Skip to main content
Signal8

Laumas Sandeep

SEC insider (Form 3/4/5 filer). CIK 0001721664. Director at Unicycive Therapeutics, Inc. (UNCY) and 2 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in MOUNTAIN VIEW, CA.

Companies Laumas Sandeep has filed insider reports for

  • Unicycive Therapeutics, Inc. (UNCY): Director
  • BioXcel Therapeutics, Inc. (BTAI): Director
  • Instil Bio, Inc. (TIL): Officer, CFO and CBO
Laumas Sandeep profile photo

Laumas Sandeep

CIK: 0001721664

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (15.4%)

Position reduction

Option Exercises (M)2 (15.4%)

Derivative conversions

Awards (A)9 (69.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Unicycive Therapeutics, Inc. logo
UNCY

Unicycive Therapeutics, Inc.

Director
BioXcel Therapeutics, Inc. logo
BTAI

BioXcel Therapeutics, Inc.

Director
Instil Bio, Inc. logo
TIL

Instil Bio, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • Unicycive Therapeutics, Inc. logo
    UNCY

    Unicycive Therapeutics, Inc.

    May 14, 2026
    Award

    Restricted Stock Units

    Direct
    47.9K shares-
  • Unicycive Therapeutics, Inc. logo
    UNCY

    Unicycive Therapeutics, Inc.

    May 14, 2026
    Award

    Restricted Stock Units

    Direct
    42.1K shares-
  • Unicycive Therapeutics, Inc. logo
    UNCY

    Unicycive Therapeutics, Inc.

    May 14, 2026
    Award

    Restricted Stock Units

    Direct
    84.2K shares-
  • Unicycive Therapeutics, Inc. logo
    UNCY

    Unicycive Therapeutics, Inc.

    May 14, 2026
    Award

    Restricted Stock Units

    Direct
    84.2K shares-
  • Unicycive Therapeutics, Inc. logo
    UNCY

    Unicycive Therapeutics, Inc.

    May 14, 2026
    Award

    Restricted Stock Units

    Direct
    42.1K shares-
  • BioXcel Therapeutics, Inc. logo
    BTAI

    BioXcel Therapeutics, Inc.

    Jan 9, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    17K shares-
  • Instil Bio, Inc. logo
    TIL

    Instil Bio, Inc.

    Sep 10, 2025
    Sale
    Direct
    17.5K shares at avg. $23.04$404K
  • Instil Bio, Inc. logo
    TIL

    Instil Bio, Inc.

    Sep 10, 2025
    Exercise
    Direct
    17K shares at avg. $11.60$197K
  • Instil Bio, Inc. logo
    TIL

    Instil Bio, Inc.

    Sep 10, 2025
    Sale
    Direct
    12.5K shares at avg. $23.88$298K
  • Instil Bio, Inc. logo
    TIL

    Instil Bio, Inc.

    Sep 10, 2025
    Exercise
    Direct
    13K shares at avg. $12.68$165K

1-10 of 13